Gentamicin Injection, USP, (PEDIATRIC), 20 mg per 2 mL (10 mg per mL*), 2 mL Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ, 08520 Vial- NDC 55150-401-01, Carton NDC 55150-401-25
Published June 25, 2025 · Recall initiated: May 29, 2025
Summary
FDA records drug Class II recall D-0472-2025, published June 25, 2025 and initiated May 29, 2025. Recalling firm: Eugia US LLC; Status: Ongoing; Reported quantity: 48,000 vials; Lot: Batch 3GT23006, 3GT23007, 3GT23008, Exp Date: November, 30, 2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Stability Specifications: Out of specification results for the Color Absorbance test during 12 Month sample analysis.
What to do
Voluntary: Firm initiated · Letter
Get an email if GENTAMICIN has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- GENTAMICIN
- Manufacturer
- Eugia US LLC
- Distributor
- Nationwide in the USA
- Lot
- Batch 3GT23006, 3GT23007, 3GT23008, Exp Date: November, 30, 2025
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAAcetaminophen Tablets, 325 mg, 100-count bottles, Distributed by: Amazon.com Services LLC, 410 Terry AvenueJune 25, 2025
- FDAUNAVY ACIDO HIALURONICO, Conenido: 30 capletas de 850mg, distribuido por: EREN NATURAL S.A. DE C.V, Zappan,June 25, 2025
- FDAUMOVY ACIDO HIALURONICO, Conenido: 30 capletas de 850mg, distribuido por: EREN NATURAL S.A. DE C.V, Zappan,June 25, 2025
- FDABrand Name: SmartRelease ESTR (Endoscopic soft tissue release system), Onyx Blade Assembly; alternate name:June 18, 2025
- FDABD TEXIUM CLOSED MALE LUER WITH FEMALE CAP, REF: 10012241-0500June 18, 2025
- FDAGENTAMICIN INJECTION, USP, equivalent to 40 mg/mL, Rx only, 20 mL Multiple Dose Vial, Manufactured by APPDecember 17, 2014
Questions about this recall
Was Gentamicin Injection, USP, (PEDIATRIC), 20 mg per 2 mL (10 mg per mL*), 2 mL Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ, 08520 Vial- NDC 55150-401-01, Carton NDC 55150-401-25 recalled?
Yes. FDA published recall D-0472-2025 on June 25, 2025. Reported hazard: Failed Stability Specifications: Out of specification results for the Color Absorbance test during 12 Month sample analysis.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: GENTAMICIN.